Significant pharmaceutical firms have shown they are going to utilize the courts and also the ITC to shield patented compounds. The legal runway for grey-market operations is shrinking.The money implications are very clear: every dollar which was flowing to gray market peptide distributors has become possibly gonna legitimate pharmaceutical channel